Related Experiment Videos
Biomarkers in heart failure management
1Foothills Medical Centre/University of Calgary, Calgary, Alberta, Canada. dlisaac@ucalgary.ca
Current Opinion in Cardiology
|February 28, 2008
Summary
B-type natriuretic peptide (BNP) is a valuable biomarker for diagnosing and predicting outcomes in heart failure. While BNP aids in management and reduces costs, its interpretation requires understanding ventricular stress and assay limitations.
Area of Science:
- Cardiology
- Biomarker Research
- Heart Failure Management
Background:
- Biomarkers are increasingly utilized in heart failure (HF) diagnosis and management.
- B-type natriuretic peptide (BNP) has emerged as a key biomarker in HF.
Purpose of the Study:
- To review the current literature on the role of biomarkers in heart failure.
- To focus on the specific applications and implications of B-type natriuretic peptide (BNP) in HF.
Main Methods:
- Literature review of recent studies on biomarkers in heart failure.
- Analysis of B-type natriuretic peptide (BNP) utilization, interpretation, and prognostic value.
Main Results:
- Understanding ventricular stress is crucial for interpreting B-type natriuretic peptide (BNP) levels.
- BNP is effective in confirming/ruling out heart failure and serves as a prognostic indicator across various patient groups.
- Serial BNP testing predicts outcomes in hospitalized patients, and guiding HF management with BNP shows promise for improved outcomes and cost reduction.
Conclusions:
- Biomarkers, including B-type natriuretic peptide (BNP), are important in HF but require further optimization.
- BNP should supplement, not replace, clinical assessment, acknowledging current assay limitations.
- Additional neurohormonal, inflammatory, and metabolic markers may offer complementary information to BNP assays.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...